Ponday, Ronald D.

HRN: 26-93-49  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2025
CEFTAZIDIME 1GM (VIAL)
04/08/2025
04/15/2025
IV
2g
Q8
CAP-HR (hypotension), PTB Presumptive
Waiting Final Action 

Indication:  EmpiricEmpirical De-escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: